Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
----------
FTSE 100
----------
UBS raises Haleon price target to 445 (410) pence - ’buy’
----------
Deutsche Bank raises Haleon price target to 375 (340) pence - ’hold’
----------
Barclays cuts Haleon price target to 406 (407) pence - ’overweight’
----------
Goldman Sachs raises AstraZeneca price target to 16,046 (15,914) pence - ’buy’
----------
Goldman Sachs starts Barclays with ’buy’ - price target 290 pence
----------
Barclays raises Standard Chartered price target to 890 (850) pence - ’equal weight’
----------
Barclays cuts HSBC price target to 730 (800) pence - ’equal weight’
----------
Barclays cuts Informa price target to 980 (1,010) pence - ’overweight’
----------
UBS raises Entain price target to 780 (680) pence - ’neutral’
----------
FTSE 250
----------
UBS raises abrdn price target to 147 (142) pence - ’sell’
----------
UBS cuts Man Group price target to 290 (295) pence - ’buy’
----------
UBS raises Jupiter Fund price target to 90 (86) pence - ’neutral’
----------
UBS raises Ashmore price target to 195 (180) pence - ’neutral’
----------
Goldman Sachs raises Hammerson price target to 274 pence - ’sell’
----------
UBS raises Travis Perkins price target to 940 (905) pence - ’neutral’
----------
Barclays cuts Tate & Lyle price target to 800 (820) pence - ’equal weight’
----------
Barclays raises Harbour Energy price target to 380 (360) pence - ’overweight’
----------
SMALL CAP
----------
Berenberg cuts Impax Asset Management price target to 560 (620) pence - ’buy’
----------
Deutsche Bank cuts Iomart target to 85 (160) pence - ’hold’
----------
Berenberg raises Renew Holdings price target to 1,350 (1,250) pence - ’buy’
----------
Deutsche Bank raises Renew Holdings target to 1,305 (1,235) pence - ’buy’
----------
Copyright 2024 Alliance News Ltd. All Rights Reserved.